ANI PHARMACEUTICALS INC (ANIP) has 13 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 10 sales totalling $1.9M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 15, 2026 | Lalwani Nikhil PRESIDENT & CEO | −$383,400 | 5,400 | −2% | Yes | |
|
|
||||||
| Sept. 14, 2026 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | −$35,395 | 500 | −1% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 11, 2026 | Thoma Jeanne Director | −$71,530 | 1,000 | −4% | Yes | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 31, 2026 | CAREY STEPHEN P. SVP & CFO | −$207,480 | 2,850 | −2% | Yes | |
|
|
||||||
| Aug. 27, 2026 filed Aug. 19, 2026 | Gosebruch Henry O Director | $0 | 6,662 | New | No | |
|
|
||||||
Showing the 5 most recent of 13 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free